₹12,486.60-171.20 (-1.35%)
13-Sep-2024₹12,517.55-165.15 (-1.30%)
13-Sep-2024BSE : 524558
NSE : NEULANDLAB
Sector : Health care
ISIN Code : INE794A01010
Last Updated: 13-Sep-2024
Market Cap (₹ Cr) | 16,020 |
Traded Value (₹ Cr) | 1.97 |
Volume (Shares) | 1,575 |
Face Value (₹) | 10 |
52-Week High (₹) | 13,248.15 |
52-Week High Date | 06-Sep-2024 |
52-Week Low (₹) | 3,528.00 |
52-Week Low Date | 22-Sep-2023 |
All Time High (₹) | 13,248.15 |
All Time High Date | 06-Sep-2024 |
All Time Low (₹) | 13.63 |
All Time Low Date | 17-Jun-1997 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 16,060 |
EPS - TTM (₹) [C] | 249.83 |
P/E Ratio (X) [C] | 50.10 |
Face Value (₹) | 10 |
Latest Dividend (%) | 140.00 |
Latest Dividend Date | 12-Jul-2024 |
Dividend Yield (%) | 0.11 |
Book Value Share (₹) [C] | 999.07 |
P/B Ratio (₹) [C] | 12.53 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
HSBC Small Cap Fund (IDCW) | 376.34 | 3,01,022 | 2.22 |
HSBC Small Cap Fund (G) | 376.34 | 3,01,022 | 2.22 |
HSBC Small Cap Fund - Direct (IDCW) | 376.34 | 3,01,022 | 2.22 |
HSBC Small Cap Fund - Direct (G) | 376.34 | 3,01,022 | 2.22 |
HSBC Multi Cap Fund - Regular (G) | 59.14 | 47,300 | 1.45 |
HSBC Multi Cap Fund - Regular (IDCW) | 59.14 | 47,300 | 1.45 |
HSBC Multi Cap Fund - Direct (G) | 59.14 | 47,300 | 1.45 |
HSBC Multi Cap Fund - Direct (IDCW) | 59.14 | 47,300 | 1.45 |
Bandhan Small Cap Fund - Direct (IDCW) | 45.13 | 36,099 | 0.60 |
Bandhan Small Cap Fund - Direct (G) | 45.13 | 36,099 | 0.60 |
Load more
Today's Low/High (₹) | 12,467.70 12,828.85 |
Week Low/High (₹) | 12,121.10 13,222.00 |
Month Low/High (₹) | 11,100.00 13,222.00 |
Year Low/High (₹) | 3,522.00 13,222.00 |
All time Low/High (₹) | 13.63 13,222.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -2.97% | -3.00% | 2.10 | 2.03% |
1 Month | 9.17% | 9.02% | 4.98 | 5.04% |
3 Month | 89.99% | 90.04% | 7.92 | 8.37% |
6 Month | 121.73% | 121.82% | 13.92 | 15.27% |
1 Year | 249.29% | 248.88% | 22.86 | 26.34% |
3 Year | 625.82% | 626.86% | 42.48 | 46.10% |
Executive Chairman : D R Rao
Non Executive Director : Christopher M Cimarusti
Vice Chairman & CEO : D Sucheth Rao
Vice Chairman & M.D. : D Saharsh Rao
Company Sec. & Compli. Officer : Sarada Bhamidipati
Independent Director : Nirmala Murthy
Independent Director : Homi Rustam Khusrokhan
Independent Director : Prasad R Menon
Independent Director : Sugata Sircar
Independent Director : Pallavi Joshi Bakhru
Registered Office: 11 Th Floor Phoenix IVY Buildi, Plot No 573A-III Road No 82,Hyderabad,Telangana-500035 Ph: 91-40-30211600
Email:ir@neulandlabs.com
1. What's the Neuland Laboratories Ltd share price today?
Neuland Laboratories Ltd share price was Rs 12,486.60 at close on 13th Sep 2024. Neuland Laboratories Ltd share price was down by 1.35% from the previous closing price of Rs 12,657.80. Neuland Laboratories Ltd share price trend:
2. How can I quickly analyse the performance of the Neuland Laboratories Ltd stock?
The performance of the Neuland Laboratories Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Neuland Laboratories Ltd?
Neuland Laboratories Ltd has a market capitalisation of Rs 16,020 crore.
4. What is Neuland Laboratories Ltd's 52-week high/low share price?
The Neuland Laboratories Ltd’s 52-week high share price is Rs 13,248.15 and 52-week low share price is Rs 3,528.00.
5. Is the Neuland Laboratories Ltd profitable?
On a consolidated basis, Neuland Laboratories Ltd reported a profit of Rs 98.34 crore on a total income of Rs 465.03 crore for the quarter ended 2024. For the year ended Jun 2024, Neuland Laboratories Ltd had posted a profit of Rs 97.87 crore on a total income of Rs 465.03 crore.
6. Which are Neuland Laboratories Ltd’s peers in the Health care sector?
Neuland Laboratories Ltd’s top 5 peers in the Health care sector are ERIS Lifescience, Astrazeneca Phar, Sanofi India, Neuland Labs., Glenmark Life, Wockhardt, Caplin Point Lab.
7. Who owns how much in Neuland Laboratories Ltd?
Key changes to the Neuland Laboratories Ltd shareholding are as follows: